Real-time enrollment status for this prostatic neoplasms, castration-resistant clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:56 AM UTC
| NCT Number | NCT05743621 |
| Recruiting Status | Recruiting |
| Condition | Prostatic Neoplasms, Castration-Resistant |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Weill Medical College of Cornell University |
| Last Updated on CT.gov | November 21, 2025 (Nov 21, 2025) |
As of July 13, 2026: Clinical trial NCT05743621 is currently recruiting participants. This clinical trial study for prostatic neoplasms, castration-resistant is actively seeking new participants at 1 location across the United States. The study is sponsored by Weill Medical College of Cornell University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05743621 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05743621 was last updated Nov 21, 2025 (November 21, 2025). HelloStudys verifies this status automatically.